| Literature DB >> 11776354 |
M Nucci1, M Landau, F Silveira, N Spector, W Pulcheri.
Abstract
We evaluated the impact of applying the Infectious Diseases Society of America guidelines for febrile neutropenic patients in reducing the use of glycopeptides. Forty-five prior episodes of febrile neutropenia were compared to 97 episodes seen after application of the guidelines. Glycopeptide use was reduced from 73% to 43% of episodes (P=.0008), without changes in outcome.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11776354 DOI: 10.1086/501839
Source DB: PubMed Journal: Infect Control Hosp Epidemiol ISSN: 0899-823X Impact factor: 3.254